Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HARVARD BIOSCIENCE INC Director's Dealing 2014

Jul 2, 2014

34975_dirs_2014-07-02_81e76425-13df-41ac-8019-dda9074983ba.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2014-06-30

Reporting Person: Gagnon Robert E. (Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-06-30 Common Stock J 1739 $3.87 Acquired 6739 Direct

Footnotes

F1: Represents shares acquired under the Issuer's Employee Stock Purchase Plan.

F2: Represents the purchase price for each share purchased under the Employee Stock Purchase Plan and equals 85% of the fair market value of the common stock on June 30, 2014, being the offering date under the plan.